SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001516551-24-000089
Filing Date
2024-09-23
Accepted
2024-09-23 17:25:23
Documents
6
Period of Report
2024-09-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A skyebioscience-definitivep.htm DEF 14A 604729
2 GRAPH chart-6bc659332af649b6828.jpg GRAPHIC 131577
3 GRAPH chart-9481c9bd40514f548a1.jpg GRAPHIC 141916
4 GRAPHIC picture1.jpg GRAPHIC 5075
5 GRAPHIC screenshot2024-09x23085208a.jpg GRAPHIC 118716
6 GRAPHIC screenshot2024-09x23085556a.jpg GRAPHIC 119458
  Complete submission text file 0001516551-24-000089.txt   1318317
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42009 | Film No.: 241317091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)